Leptin: A Potential Anxiolytic by Facilitation of Fear Extinction

CNS Neuroscience and Therapeutics

Volumn 21, Issue 5, 2015, Pages 425-434

  Wang, Wei ^a,e   Liu, Song Lin ^b   Li, Kuan ^a   Chen, Yu ^b   Jiang, Bo ^a   Li, Yan Kun ^a   Xiao, Jun Li ^a   Yang, Si ^a   Chen, Tao ^a   Chen, Jian Guo ^a,c,d   Li, Jia Geng ^b   Wang, Fang ^a,c,d  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUBEI UNIVERSITY OF CHINESE MEDICINE   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^e NANCHANG UNIVERSITY   (China)

Author keywords

Amygdala; Anxiety; Fear conditioning; Leptin; Long term potentiation

Indexed keywords

ANXIOLYTIC AGENT; DIZOCILPINE; LEPTIN; MITOGEN ACTIVATED PROTEIN KINASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; AMINO ACID RECEPTOR BLOCKING AGENT; DIZOCILPINE MALEATE; RECOMBINANT PROTEIN;

ACUTE STRESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; ELECTRIC POTENTIAL; FEAR; IN VITRO STUDY; LATERAL AMYGDALA; LONG TERM POTENTIATION; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PERIRHINAL CORTEX; PROTEIN PHOSPHORYLATION; RAT; SYNAPSE; SYNAPTIC POTENTIAL; SYNAPTIC TRANSMISSION; THALAMUS; TRANQUILIZING ACTIVITY; ANIMAL; ANTAGONISTS AND INHIBITORS; ANXIETY; BASOLATERAL AMYGDALA; C57BL MOUSE; CONDITIONING; DOSE RESPONSE; DRUG EFFECTS; DRUG THERAPY; METABOLISM; NERVE TRACT; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION; REINFORCEMENT; TISSUE CULTURE TECHNIQUE;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BASOLATERAL NUCLEAR COMPLEX; CONDITIONING (PSYCHOLOGY); DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; EXTINCTION, PSYCHOLOGICAL; FEAR; LEPTIN; LONG-TERM POTENTIATION; MICE, INBRED C57BL; NEURAL PATHWAYS; RANDOM ALLOCATION; RECEPTORS, N-METHYL-D-ASPARTATE; RECOMBINANT PROTEINS; SYNAPTIC TRANSMISSION; THALAMUS; TISSUE CULTURE TECHNIQUES;

EID: 84928051850     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12375     Document Type: Article

References (41)

1. Myers KM, Davis M. Mechanisms of fear extinction. Mol Psychiatry 2007;12:120-150.
2. Garakani A, Mathew SJ, Charney DS. Neurobiology of anxiety disorders and implications for treatment. Mt Sinai J Med 2006;73:941-949.
3. Schafe GE, Doyere V, LeDoux JE. Tracking the fear engram: the lateral amygdala is an essential locus of fear memory storage. J Neurosci 2005;25:10010-10014.
4. McKernan MG, Shinnick-Gallagher P. Fear conditioning induces a lasting potentiation of synaptic currents in vitro. Nature 1997;390:607-611.
5. Hobin JA, Goosens KA, Maren S. Context-dependent neuronal activity in the lateral amygdala represents fear memories after extinction. J Neurosci 2003;23:8410-8416.
6. Kim J, Lee S, Park K, et al. Amygdala depotentiation and fear extinction. Proc Natl Acad Sci USA 2007;104:20955-20960.
7. Amaral OB, Roesler R. Targeting the NMDA receptor for fear-related disorders. Recent Pat CNS Drug Discov 2008;3:166-178.
8. Falls WA, Miserendino MJ, Davis M. Extinction of fear-potentiated startle: blockade by infusion of an NMDA antagonist into the amygdala. J Neurosci 1992;12:854-863.
9. Pinto S, Roseberry AG, Liu H, et al. Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science 2004;304:110-115.
10. Morash B, Li A, Murphy PR, Wilkinson M, Ur E. Leptin gene expression in the brain and pituitary gland. Endocrinology 1999;140:5995-5998.
11. Harvey J, Solovyova N, Irving A. Leptin and its role in hippocampal synaptic plasticity. Prog Lipid Res 2006;45:369-378.
12. Shanley LJ, Irving AJ, Harvey J. Leptin enhances NMDA receptor function and modulates hippocampal synaptic plasticity. J Neurosci 2001;21:RC186.
13. Oomura Y, Hori N, Shiraishi T, et al. Leptin facilitates learning and memory performance and enhances hippocampal CA1 long-term potentiation and CaMK II phosphorylation in rats. Peptides 2006;27:2738-2749.
14. Lu XY, Kim CS, Frazer A, Zhang W. Leptin: a potential novel antidepressant. Proc Natl Acad Sci USA 2006;103:1593-1598.
15. Liu J, Perez SM, Zhang W, Lodge DJ, Lu XY. Selective deletion of the leptin receptor in dopamine neurons produces anxiogenic-like behavior and increases dopaminergic activity in amygdala. Mol Psychiatry 2011;16:1024-1038.
16. Finger BC, Dinan TG, Cryan JF. Leptin-deficient mice retain normal appetitive spatial learning yet exhibit marked increases in anxiety-related behaviours. Psychopharmacology 2010;210:559-568.
17. Raber J, Chen S, Mucke L, Feng L. Corticotropin-releasing factor and adrenocorticotrophic hormone as potential central mediators of OB effects. J Biol Chem 1997;272:15057-15060.
18. Udagawa J, Hatta T, Naora H, Otani H. Expression of the long form of leptin receptor (Ob-Rb) mRNA in the brain of mouse embryos and newborn mice. Brain Res 2000;868:251-258.
19. Baker JD, Azorlosa JL. The NMDA antagonist MK-801 blocks the extinction of Pavlovian fear conditioning. Behav Neurosci 1996;110:618-620.
20. Wang W, Wang F, Yang YJ, et al. The flavonoid baicalein promotes NMDA receptor-dependent long-term potentiation and enhances memory. Br J Pharmacol 2011;162:1364-1379.
21. Liu JL, Li M, Dang XR, et al. A NMDA receptor antagonist, MK-801 impairs consolidating extinction of auditory conditioned fear responses in a Pavlovian model. PLoS One 2009;4:e7548.
22. Farr SA, Banks WA, Morley JE. Effects of leptin on memory processing. Peptides 2006;27:1420-1425.
23. Harvey J. Leptin regulation of neuronal excitability and cognitive function. Curr Opin Pharmacol 2007;7:643-647.
24. Clem RL, Huganir RL. Calcium-permeable AMPA receptor dynamics mediate fear memory erasure. Science 2010;330:1108-1112.
25. Lin CH, Lee CC, Gean PW. Involvement of a calcineurin cascade in amygdala depotentiation and quenching of fear memory. Mol Pharmacol 2003;63:44-52.
26. Lin CH, Lee CC, Huang YC, Wang SJ, Gean PW. Activation of group II metabotropic glutamate receptors induces depotentiation in amygdala slices and reduces fear-potentiated startle in rats. Learn Mem 2005;12:130-137.
27. Welch JM, Lu J, Rodriguiz RM, et al. Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature 2007;448:894-900.
28. Durakoglugil M, Irving AJ, Harvey J. Leptin induces a novel form of NMDA receptor-dependent long-term depression. J Neurochem 2005;95:396-405.
29. Moult PR, Milojkovic B, Harvey J. Leptin reverses long-term potentiation at hippocampal CA1 synapses. J Neurochem 2009;108:685-696.
30. Fei H, Okano HJ, Li C, et al. Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc Natl Acad Sci USA 1997;94:7001-7005.
31. Zhang F, Wang S, Signore AP, Chen J. Neuroprotective effects of leptin against ischemic injury induced by oxygen-glucose deprivation and transient cerebral ischemia. Stroke 2007;38:2329-2336.
32. Fulton S, Pissios P, Manchon RP, et al. Leptin regulation of the mesoaccumbens dopamine pathway. Neuron 2006;51:811-822.
33. Liu J, Garza JC, Bronner J, Kim CS, Zhang W, Lu XY. Acute administration of leptin produces anxiolytic-like effects: a comparison with fluoxetine. Psychopharmacology 2009;207:535-545.
34. Rodriguez Manzanares PA, Isoardi NA, Carrer HF, Molina VA. Previous stress facilitates fear memory, attenuates GABAergic inhibition, and increases synaptic plasticity in the rat basolateral amygdala. J Neurosci 2005;25:8725-8734.
35. Barad M, Gean PW, Lutz B. The role of the amygdala in the extinction of conditioned fear. Biol Psychiatry 2006;60:322-328.
36. Monfils MH, Cowansage KK, Klann E, LeDoux JE. Extinction-reconsolidation boundaries: key to persistent attenuation of fear memories. Science 2009;324:951-955.
37. Hong I, Song B, Lee S, Kim J, Choi S. Extinction of cued fear memory involves a distinct form of depotentiation at cortical input synapses onto the lateral amygdala. Eur J Neurosci 2009;30:2089-2099.
38. Pallister E, Waller G. Anxiety in the eating disorders: under-standing the overlap. Clin Psychol Rev 2008;28:366-386.
39. Liao SC, Lee MB, Lee YJ, Huang TS. Hyperleptinemia in subjects with persistent partial posttraumatic stress disorder after a major earthquake. Psychosom Med 2004;66:23-28.
40. von Känel R, Begré S, Abbas CC, Saner H, Gander ML, Schmid JP. Inflammatory biomarkers in patients with posttraumatic stress disorder caused by myocardial infarction and the role of depressive symptoms. NeuroImmunoModulation 2010;17:39-46.
41. Jow GM, Yang TT, Chen CL. Leptin and cholesterol levels are low in major depressive disorder, but high in schizophrenia. J Affect Disord 2006;90:21-27.